No Data
No Data
No Data
Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 8, 2024
Yahoo FinanceApr 24 16:05 ET
ACADIA Pharmaceuticals (NASDAQ:ACAD) Is In A Strong Position To Grow Its Business
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares sinc
Simply Wall StApr 24 10:42 ET
Express News | Acadia Pharmaceuticals Announces Trofinetide New Drug Submission For Treatment Of Rett Syndrome Accepted For Filing And Priority Review By Health Canada
Moomoo 24/7Apr 22 09:06 ET
Express News | ACADIA Pharmaceuticals Announces Trofinetide New Drug Submission for Treatment of Rett Syndrome Has Been Accepted for Filing and Priority Review by Health Canada
Moomoo 24/7Apr 22 09:04 ET
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock
BusinesswireApr 19 16:05 ET
Express News | ACADIA Pharmaceuticals Inc : Needham Cuts Target Price to $30 From $32: Needham Cuts Target Price to $30 From $32
Moomoo 24/7Apr 19 05:35 ET
Jaguar8 : Again.
TrytosaveabitOP Jaguar8: Yup! Another that’s probably going to plummet?
Jaguar8 TrytosaveabitOP: Big time plummet. I hope nobody is left bagholding
TrytosaveabitOP Jaguar8: You and me both! Even if it has a great pipeline with others soon to be reported! These are dangerous plays for just that reason! Some are just a huge overreaction! Some are not though.
Jaguar8 TrytosaveabitOP: It’s like NERV